Lifeward Ltd. Research And Development Expense

• Lifeward Ltd. showed a decrease of -29.8% in Research And Development Expense from 2024 to 2025.
• This data is from Lifeward Ltd.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
• XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2015: $1.54 million | Q2 2015: $1.45 million | Q3 2015: $1.26 million | Q1 2016: $1.70 million | Q2 2016: $3.07 million | Q3 2016: $1.97 million | Q1 2017: $1.43 million | Q2 2017: $1.39 million | Q3 2017: $1.62 million | Q1 2018: $2.15 million | Q2 2018: $1.90 million | Q3 2018: $1.60 million | Q1 2019: $1.41 million | Q2 2019: $1.86 million | Q3 2019: $1.02 million | Q1 2020: $985.0 thousand | Q2 2020: $954.0 thousand | Q3 2020: $756.0 thousand | Q1 2021: $795.0 thousand | Q2 2021: $810.0 thousand | Q3 2021: $638.0 thousand | Q1 2022: $907.0 thousand | Q2 2022: $956.0 thousand | Q3 2022: $1.07 million | Q1 2023: $752.0 thousand | Q2 2023: $816.0 thousand | Q3 2023: $1.26 million | Q1 2024: $1.29 million | Q2 2024: $1.21 million | Q3 2024: $998.0 thousand | Q1 2025: $918.0 thousand | Q2 2025: $767.0 thousand | Q3 2025: $721.0 thousand.
• Over the full 13 years of available data (2013 to 2025), Lifeward Ltd.'s Research And Development Expense has grown by 31.9%.
• Historical annual values: Fiscal year 2025: $3.25 million | Fiscal year 2024: $4.63 million | Fiscal year 2023: $4.15 million | Fiscal year 2022: $4.03 million | Fiscal year 2021: $2.94 million | Fiscal year 2020: $3.46 million | Fiscal year 2019: $5.35 million | Fiscal year 2018: $7.35 million | Fiscal year 2017: $6.04 million | Fiscal year 2016: $9.03 million | Fiscal year 2015: $5.94 million | Fiscal year 2014: $8.56 million | Fiscal year 2013: $2.46 million.
• Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: August 7, 2026